SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Credit Suisse Group AG (CS) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+1254.7%).
- Analyst consensus target $12.00 (+1254.7% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 48/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CS
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.16
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.97
Book Value / Share$0.00
Revenue / Share$5.60
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$12.00 (+1254.7%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$1.42 |
$23.84B |
$2.33B |
9.8% |
| 2014 |
$1.08 |
$24.04B |
$1.88B |
7.8% |
| 2015 |
$-1.66 |
$21.77B |
$-2.94B |
-13.5% |
| 2016 |
$-1.28 |
$17.74B |
$-2.71B |
-15.3% |
| 2017 |
$-0.41 |
$19.24B |
$-983M |
-5.1% |
| 2018 |
$0.79 |
$19.3B |
$2.02B |
10.5% |
| 2019 |
$1.25 |
$20.47B |
$3.42B |
16.7% |
| 2020 |
$1.00 |
$21.13B |
$2.67B |
12.6% |
| 2021 |
$-0.62 |
$15.99B |
$-1.63B |
-10.2% |
| 2022 |
$-2.97 |
$13.76B |
$-7.31B |
-53.1% |
